Drug
Ademetionine
Ademetionine: highest development phase Phase 3, developed by Abbott Laboratories. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Abbott Laboratories
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ademetionine IV+tablet NCT02200029 | Phase 3 | Intrahepatic Cholestasis Associated With Alcoholic Liver Disease |
Latest
No recent events.
Follow Ademetionine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.